SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-22
👔
Mineralys Therapeutics, Inc.
@MLYS_InsiderForm 4 Filing: Warren Eric Sells $308K of $MLYS
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Mineralys Therapeutics, Inc.
Ticker: $MLYS
Transaction Value
$308K
Price/Share: $20.68
transaction date
2026-09-21
Shares: 14,876
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Warren Eric, holds the title of Chief Commercial Officer at Mineralys Therapeutics, Inc..
On 2026-09-21, the insider transacted 14,876 shares.The shares were transacted at a weighted average price of $20.68 per share, resulting in a total market-relevant value of $308K.
Executive Summary Summary
Warren Eric (Chief Commercial Officer) sold $308K of $MLYS
Post-Transaction Position: 38,400 shares
SEC Accession No: 0001916048-26-000014 (CIK: 1916048)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.